Olema Pharmaceuticals (OLMA) Stock Forecast & Price Target

OLMA$7.56+0.04 +0.53%
BiotechnologyGrowth Stock
Compare
Market cap$662.30MEnterprise value$624.75MRevenue (TTM)$0Market position—

Score

68
Bullish
Value
57
Quality
46
Growth
100

Olema Pharmaceuticals, Inc. price target

OLMA
Low$20.00
Average$28.33
High$35.00
Upside vs current price+274.7%

The average target of $28.33 is +274.7% versus the current OLMA price of $7.56.

Olema Pharmaceuticals, Inc. analyst ratings

RatingAnalysts
Strong buy2
Buy9
Hold1
Sell0
Strong sell0
ConsensusBuy

12 analysts cover OLMA.

Olema Pharmaceuticals, Inc. EPS and revenue estimates

OLMA shows the next fiscal years with at least three analysts: 2026 EPS $-2.60, 2027 EPS $-2.90. A thinner year is left off this table.

Fiscal yearEPS estimateRevenue estimate
2026$-2.60$2.25M
2027$-2.90$8.19M

Is Olema Pharmaceuticals, Inc. a buy or sell?

Of the 12 analysts covering Olema Pharmaceuticals, Inc., 11 rate it a buy (2 strong buy and 9 buy), 1 rates it a hold, and 0 rate it a sell (0 sell and 0 strong sell).

The OLMA consensus label is Buy, beside 11 buy-side ratings and 0 sell-side ratings.

The average target of $28.33 implies +274.7% versus the current price of $7.56.

Those 12 ratings on OLMA are a headcount, and the label on file is Buy.

Reading the Olema Pharmaceuticals, Inc. forecast

The OLMA target range is wide: $20.00 at the low end, $28.33 in the middle, and $35.00 at the top.

Set next to the $7.56 OLMA quote, that average is +274.7%.

Ratings on the Olema Pharmaceuticals, Inc. cluster: 11 of 12 analysts are on the buy side, 1 is at hold, and 0 are on the sell side, and the published consensus is Buy.

The OLMA EPS path from 2026 ($-2.60) to 2027 ($-2.90) is falling.

Only 12 analysts cover OLMA, so the average rests on a short list.

Olema Pharmaceuticals, Inc. forecast questions

What is the OLMA price target?

The published range for OLMA is $20.00 to $35.00, with an average of $28.33. That average is +274.7% versus the current price of $7.56.

Is Olema Pharmaceuticals, Inc. a buy or sell?

Of the 12 analysts covering Olema Pharmaceuticals, Inc., 11 rate it a buy, 1 rates it a hold, and 0 rate it a sell. The consensus is Buy, and the OLMA headcount is 11 buy, 1 hold, and 0 sell.

What is the EPS estimate for Olema Pharmaceuticals, Inc.?

Analyst EPS estimates for Olema Pharmaceuticals, Inc.: 2026 $-2.60, 2027 $-2.90.

What is the revenue estimate for Olema Pharmaceuticals, Inc.?

Analyst revenue estimates for Olema Pharmaceuticals, Inc.: 2026 $2.25M, 2027 $8.19M.

How many analysts cover OLMA?

12 analysts cover OLMA. Their consensus on OLMA is Buy, across those 12.

OLMA price $7.56 +0.04 +0.53%

Insights · Forecast · Financials · Learn

Stocklytics home · Screener